Development of drug resistance to HIV-1 protease inhibitors.
Case Western Reserve University, School of Medicine, Cleveland, Ohio 44106-4935, USA.
T
T
Ridky
J
J
Leis
D000595:Amino Acid Sequence; D017124:Conserved Sequence; D004352:Drug Resistance, Microbial; D005814:Genes, Viral; D016333:HIV Protease / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology / Q000502:physiology; D006801:Humans; D007546:Isoquinolines / Q000737:chemistry / Q000494:pharmacology; D008961:Models, Structural; D017354:Point Mutation; D017433:Protein Structure, Secondary; D011804:Quinolines / Q000737:chemistry / Q000494:pharmacology; D019258:Saquinavir
D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D011804:Quinolines; D016333:HIV Protease; D019258:Saquinavir